• STT3B, ICG, and α-Amanitin Cytotoxicity

  2026-08-11

  The reference study combines a genome-wide CRISPR knockout screen, computational drug screening, and validation in cells, liver organoids, and mice to identify STT3B as a critical determinant of α-amanitin toxicity. Its findings position indocyanine green as a candidate STT3B inhibitor and provide a mechanistic framework for studying mushroom toxin cytotoxicity beyond direct RNA polymerase II inhibition.

• JTW and Coptisine Rewire PCOS Steroidogenesis

  2026-08-10

  The 2025 Phytomedicine study identifies SIRT1 ubiquitination and mitochondrial cholesterol import as a mechanistic link between Jiao-tai-wan, coptisine, and abnormal ovarian steroidogenesis in a DHEA-induced PCOS rat model. Its integrated animal, cellular, transcriptomic, imaging, and target-validation strategy provides a useful framework for studying how mitochondrial steroidogenic control contributes to PCOS phenotypes.

• Hippo Signaling in Hepatobiliary Cell Maturation

  2026-08-09

  This preprint identifies two largely independent Hippo pathway modules, HPO1 and HPO2, as stage- and cell-type-specific checkpoints for hepatocyte and cholangiocyte maturation. Spatial transcriptomics and imaging in genetically perturbed mouse livers reveal distinct immature cell states that also emerge during regeneration, refining the view of Hippo signaling beyond simple control of organ size.

• Prochlorperazine: Applied Cell Research Workflows

  2026-08-08

  Prochlorperazine is a dopamine D2 receptor antagonist with practical value across antiemetic therapy, melanoma research, and mechanistic membrane-trafficking assays. This workflow-focused guide explains solvent handling, concentration selection, assay controls, and how to translate clinical-study design principles into reproducible laboratory experiments.

• Bortezomib (PS-341) for Proteostasis Assays

  2026-08-07

  Bortezomib (PS-341) provides a reversible 20S proteasome perturbation for connecting protein turnover, apoptosis, and neuronal stress phenotypes. This workflow positions it as an orthogonal tool alongside DCPS/TDP-43 genetic experiments rather than as a direct P-body pathway inhibitor.

• L-NAME Hydrochloride: Reliable NOS Inhibition for Cell Viabi

  2026-08-07

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity studies, focusing on the reproducibility and data integrity enabled by L-NAME Hydrochloride (SKU A7088). Using scenario-driven Q&A, we provide evidence-based insights for selecting, optimizing, and interpreting results with this benchmark NOS inhibitor—grounded in quantitative data and direct protocol guidance.

• A40926: Dalbavancin Precursor for Gram-Positive Pathogen Res

  2026-08-06

  A40926 is a natural glycopeptide antibiotic and the direct precursor to dalbavancin, exhibiting potent and well-characterized bactericidal activity against Gram-positive bacteria and Neisseria gonorrhoeae. Its precise inhibition of bacterial cell wall synthesis and pathogen-specific MIC values make it indispensable for in vitro antibacterial assays and advanced antibiotic development.

• Bortezomib (PS-341): Applied Proteasome Inhibition in Cancer

  2026-08-06

  Bortezomib (PS-341) delivers robust, selective 20S proteasome inhibition, enabling high-sensitivity apoptosis and cell viability assays across cancer models. This article translates recent mechanistic insights and workflow advances into actionable protocols and troubleshooting strategies, spotlighting how Bortezomib from APExBIO empowers reproducible research.

• Doxorubicin Hydrochloride: Applied Workflows in Chemotherapy

  2026-08-05

  Harness the power of Doxorubicin hydrochloride in both cancer chemotherapy research and cardiotoxicity modeling. This article delivers actionable workflow enhancements, protocol optimization, and troubleshooting strategies to maximize experimental reproducibility and mechanistic insight.

• Pronase E Protease Mixture: Precision in Unbiased Protein Di

  2026-08-05

  Explore the advanced science and workflow impact of Pronase E, a potent protease mixture, for protein sample preparation and proteomic innovation. This cornerstone article offers unique mechanistic insights and practical guidance for researchers seeking superior results.

• Baricitinib (LY3009104): Applied Protocols for JAK1/2 Inhibi

  2026-08-04

  Baricitinib (LY3009104) offers high selectivity and reproducible inhibition of JAK1/2-driven cytokine pathways, making it indispensable for dissecting inflammatory signaling in disease models. This guide translates cutting-edge spatial proteomics findings into actionable protocols, troubleshooting, and workflow optimization for immune modulation research.

• Letrozole: Applied Workflows for Non-Steroidal Aromatase Inh

  2026-08-04

  Letrozole stands out as a potent, reversible non-steroidal aromatase inhibitor, enabling precision estrogen pathway modulation across breast cancer and neuroendocrine research. Discover protocol-ready parameters, troubleshooting tips, and comparative insights that translate bench evidence into robust experimental outcomes.

• Gepotidacin Applications: Protocols & Troubleshooting in Ant

  2026-08-03

  Gepotidacin (GSK2140944) revolutionizes antibacterial research by targeting DNA replication in resistant bacteria. This article delivers stepwise protocols, advanced troubleshooting, and evidence-backed optimization strategies to maximize experimental success with this next-generation topoisomerase inhibitor.

• Redefining Epithelial Repair Detection: Cy5 TSA in IBD Resea

  2026-08-03

  Explore how next-generation signal amplification technology, exemplified by the Cy5 TSA Fluorescence System Kit, is revolutionizing the detection of low-abundance targets and mechanistic studies of mucosal repair in inflammatory bowel disease. Integrating mechanistic insight from recent NET-ILC3-CCDC25 discoveries, this article guides translational researchers in leveraging advanced HRP-catalyzed tyramide deposition for high-sensitivity, quantitative mapping of immune and barrier processes in complex tissue microenvironments.

• CAY10499: Advanced Strategies for Lipid Metabolism and Immun

  2026-08-02

  Explore the unique biochemical properties and research applications of CAY10499, a potent inhibitor of human hormone sensitive lipase. This article delivers new insights on integrating CAY10499 into immunometabolic workflows and lipid metabolism assay design.

8622 records 3/575 page Previous Next 12345 下5页 Last page